Feedback / Questions
EBC-129 - A*Star, National Cancer Centre Singapore
https://www.newswire.ca/news-releases/experimental-drug-development-centre-granted-u-s-fda-fast-track-designation-for-antibody-drug-conjugate-ebc-129-to-treat-pancreatic-ductal-adenocarcinoma-802412670.html
May 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next